Editors at The BMJ have warned that President Trump’s policies could damage biomedical research and regulation around the world.

Immunexpress earned 510(k) clearance for its RNA-based clinical diagnostic that detects sepsis in critically ill patients. The test, which uses whole blood,…

Celiacs could be freed from the gluten-free aisle of the supermarket if a therapeutic approach developed by ImmusanT proves effective in trials.

Argos' cancer vaccine candidate failed a phase 3 futility analysis, wiping 65% off its stock.

Apitope has posted phase 2a data on the multiple sclerosis drug Merck KGaA walked away from last year.

IBM Watson was set to announce new partnerships on Monday, but reports of the company’s partnership with MD Anderson being put on hold may have stolen its…

VBL Therapeutics has presented more data from a phase 2 trial of VB-111 monotherapy in thyroid cancer patients.

Cidara Therapeutics will stop work on its antifungal CD101 in women with acute VVC, after the topical candidate failed a mid-stage trial.

Pfizer said the FDA has given its experimental leukemia med inotuzumab ozogamicin a priority review as it gets to work on assessing the medication for approval.